This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Buettner, C. Articles by Larsen, P. R. Search for Related Content PubMed PubMed Citation Articles by Buettner, C. Articles by Larsen, P. R. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB (L)-ALANINE CYSTEINE LEVOTHYROXINE LIOTHYRONINE

The Role of Selenocysteine 133 in Catalysis by the Human Type 2 Iodothyronine Deiodinase¹

Thyroid Division, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts 02115

Address all correspondence and requests for reprints to: Dr. P. Reed Larsen, Thyroid Division, Brigham and Women’s Hospital and Harvard Medical School, 77 Avenue Louis Pasteur, Boston, Massachusetts 02115. E-mail: larsen{at}rascal.med.harvard.edu

Human type 2 iodothyronine deiodinase (NOREF>hD2) catalyzes the activation of T₄ to T₃. D2, like types 1 and 3 deiodinases, contains selenocysteine (Sec) in the highly conserved active center at position 133. To evaluate the contribution of Sec¹³³ to the catalytic properties of hD2, we generated mutants in which cysteine (Cys) or alanine (Ala) replaced Sec¹³³. The K_m (T₄) of Cys¹³³ D2 was 2.1 µM, strikingly higher than that of native D2 (1.4 nM). In contrast, the relative turnover number was 10-fold lower for Cys¹³³D2, illustrating the greater potency of Se than S in supporting catalysis. The AlaD2 mutant was inactive. Studies in intact cells transiently expressing the native or Cys¹³³D2 enzyme exhibited saturation kinetics expected from the K_m as measured under in vitro conditions, indicating rapid equilibration of extracellular and intracellular T₄. Blockade of the NTCP, OATP1–3, and LST-1 transporters with 10 mM sodium taurocholate did not alter the deiodination rate of T₄ by Cys¹³³D2 transiently expressed in intact cells, suggesting that intracellular transport of T₄ is not rate limiting. These results illustrate that selenium plays a critical role in deiodination catalyzed by hD2.

This article has been cited by other articles:

				W. S. da-Silva, J. W. Harney, B. W. Kim, J. Li, S. D.C. Bianco, A. Crescenzi, M. A. Christoffolete, S. A. Huang, and A. C. Bianco The Small Polyphenolic Molecule Kaempferol Increases Cellular Energy Expenditure and Thyroid Hormone Activation Diabetes, March 1, 2007; 56(3): 767 - 776. [Abstract] [Full Text] [PDF]

				M. A. Christoffolete, R. Ribeiro, P. Singru, C. Fekete, W. S. da Silva, D. F. Gordon, S. A. Huang, A. Crescenzi, J. W. Harney, E. C. Ridgway, et al. Atypical Expression of Type 2 Iodothyronine Deiodinase in Thyrotrophs Explains the Thyroxine-Mediated Pituitary Thyrotropin Feedback Mechanism Endocrinology, April 1, 2006; 147(4): 1735 - 1743. [Abstract] [Full Text] [PDF]

				T-W Guo, F-C Zhang, M-S Yang, X-C Gao, L Bian, S-W Duan, Z-J Zheng, J-J Gao, H Wang, R-L Li, et al. Positive association of the DIO2 (deiodinase type 2) gene with mental retardation in the iodine-deficient areas of China J. Med. Genet., August 1, 2004; 41(8): 585 - 590. [Abstract] [Full Text] [PDF]

				C. A. Shepherdley, W. Klootwijk, K. W. Makabe, T. J. Visser, and G. G. J. M. Kuiper An Ascidian Homolog of Vertebrate Iodothyronine Deiodinases Endocrinology, March 1, 2004; 145(3): 1255 - 1268. [Abstract] [Full Text] [PDF]

				B. W. Kim, A. M. Zavacki, C. Curcio-Morelli, M. Dentice, J. W. Harney, P. R. Larsen, and A. C. Bianco Endoplasmic Reticulum-Associated Degradation of the Human Type 2 Iodothyronine Deiodinase (D2) is Mediated via an Association between Mammalian UBC7 and the Carboxyl Region of D2 Mol. Endocrinol., December 1, 2003; 17(12): 2603 - 2612. [Abstract] [Full Text] [PDF]

				I. Callebaut, C. Curcio-Morelli, J.-P. Mornon, B. Gereben, C. Buettner, S. Huang, B. Castro, T. L. Fonseca, J. W. Harney, P. R. Larsen, et al. The Iodothyronine Selenodeiodinases Are Thioredoxin-fold Family Proteins Containing a Glycoside Hydrolase Clan GH-A-like Structure J. Biol. Chem., September 19, 2003; 278(38): 36887 - 36896. [Abstract] [Full Text] [PDF]

				G. G. J. M. Kuiper, W. Klootwijk, and T. J. Visser Substitution of Cysteine for Selenocysteine in the Catalytic Center of Type III Iodothyronine Deiodinase Reduces Catalytic Efficiency and Alters Substrate Preference Endocrinology, June 1, 2003; 144(6): 2505 - 2513. [Abstract] [Full Text] [PDF]

				C. Curcio-Morelli, B. Gereben, A. M. Zavacki, B. W. Kim, S. Huang, J. W. Harney, P. R. Larsen, and A. C. Bianco In Vivo Dimerization of Types 1, 2, and 3 Iodothyronine Selenodeiodinases Endocrinology, March 1, 2003; 144(3): 937 - 946. [Abstract] [Full Text] [PDF]

				D. Botero, B. Gereben, C. Goncalves, L. A. de Jesus, J. W. Harney, and A. C. Bianco Ubc6p and Ubc7p Are Required for Normal and Substrate-Induced Endoplasmic Reticulum-Associated Degradation of the Human Selenoprotein Type 2 Iodothyronine Monodeiodinase Mol. Endocrinol., September 1, 2002; 16(9): 1999 - 2007. [Abstract] [Full Text] [PDF]

				B. Gereben, A. Kollar, J. W. Harney, and P. R. Larsen The mRNA Structure Has Potent Regulatory Effects on Type 2 Iodothyronine Deiodinase Expression Mol. Endocrinol., July 1, 2002; 16(7): 1667 - 1679. [Abstract] [Full Text] [PDF]

				G. G. J. M. Kuiper, W. Klootwijk, and T. J. Visser Substitution of Cysteine for a Conserved Alanine Residue in the Catalytic Center of Type II Iodothyronine Deiodinase Alters Interaction with Reducing Cofactor Endocrinology, April 1, 2002; 143(4): 1190 - 1198. [Abstract] [Full Text] [PDF]

				D. Mentuccia, L. Proietti-Pannunzi, K. Tanner, V. Bacci, T. I. Pollin, E. T. Poehlman, A. R. Shuldiner, and F. S. Celi Association Between a Novel Variant of the Human Type 2 Deiodinase Gene Thr92Ala and Insulin Resistance: Evidence of Interaction With the Trp64Arg Variant of the {beta}-3-Adrenergic Receptor Diabetes, March 1, 2002; 51(3): 880 - 883. [Abstract] [Full Text] [PDF]

				A. C. Bianco, D. Salvatore, B. Gereben, M. J. Berry, and P. R. Larsen Biochemistry, Cellular and Molecular Biology, and Physiological Roles of the Iodothyronine Selenodeiodinases Endocr. Rev., February 1, 2002; 23(1): 38 - 89. [Abstract] [Full Text] [PDF]